Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 155


Timing of oral anticoagulant therapy in acute ischemic stroke with atrial fibrillation: study protocol for a registry-based randomised controlled trial.

Åsberg S, Hijazi Z, Norrving B, Terént A, Öhagen P, Oldgren J.

Trials. 2017 Dec 2;18(1):581. doi: 10.1186/s13063-017-2313-9.


To Treat or Not to Treat: Anticoagulants as Secondary Preventives to the Oldest Old With Atrial Fibrillation.

Appelros P, Farahmand B, Terént A, Åsberg S.

Stroke. 2017 Jun;48(6):1617-1623. doi: 10.1161/STROKEAHA.117.016902. Epub 2017 May 9.


Antikoagulantia efter akut ischemisk stroke med förmaksflimmer - Frågan om rätt tidpunkt för insättning kräver randomiserad klinisk prövning.

Terent A, Åsberg S, Oldgren J, Hijazi Z, Norrving B.

Lakartidningen. 2016 Mar 1;113. pii: DUFT. Swedish.


Effect of X-Ray Attenuation of Arterial Obstructions on Intravenous Thrombolysis and Outcome after Ischemic Stroke.

Mair G, von Kummer R, Lindley RI, Sandercock PA, Wardlaw JM; IST-3 Collaborative Group.

PLoS One. 2015 Dec 23;10(12):e0145683. doi: 10.1371/journal.pone.0145683. eCollection 2015.


Effect of alteplase on the CT hyperdense artery sign and outcome after ischemic stroke.

Mair G, von Kummer R, Morris Z, von Heijne A, Bradey N, Cala L, Peeters A, Farrall AJ, Adami A, Potter G, Cohen G, Sandercock PA, Lindley RI, Wardlaw JM; IST-3 Collaborative Group.

Neurology. 2016 Jan 12;86(2):118-25. doi: 10.1212/WNL.0000000000002236. Epub 2015 Dec 9.


Thrombolysis in acute stroke.

Appelros P, Terént A.

Lancet. 2015 Apr 11;385(9976):1394. doi: 10.1016/S0140-6736(15)60714-0. No abstract available.


Effects of candesartan in acute stroke on vascular events during long-term follow-up: results from the Scandinavian Candesartan Acute Stroke Trial (SCAST).

Hornslien AG, Sandset EC, Igland J, Terént A, Boysen G, Bath PM, Murray GD, Berge E.

Int J Stroke. 2015 Aug;10(6):830-5. doi: 10.1111/ijs.12477. Epub 2015 Mar 22.


[The benefit of thrombolysis in cerebral infarction--a question of measurements].

Appelros P, Terént A.

Lakartidningen. 2014 Oct 1-7;111(40):1696-7. Swedish. No abstract available.


National registry-based case-control study: comorbidity and stroke in young adults.

Bergman EM, Henriksson KM, Åsberg S, Farahmand B, Terént A.

Acta Neurol Scand. 2015 Jun;131(6):394-9. doi: 10.1111/ane.12265. Epub 2015 Feb 12.


Benefit of anticoagulation unlikely in patients with atrial fibrillation and a CHA2DS2-VASc score of 1.

Friberg L, Skeppholm M, Terént A.

J Am Coll Cardiol. 2015 Jan 27;65(3):225-32. doi: 10.1016/j.jacc.2014.10.052.


Alteplase for acute ischemic stroke: outcomes by clinically important subgroups in the Third International Stroke Trial.

Lindley RI, Wardlaw JM, Whiteley WN, Cohen G, Blackwell L, Murray GD, Sandercock PA; IST-3 Collaborative Group.

Stroke. 2015 Mar;46(3):746-56. doi: 10.1161/STROKEAHA.114.006573. Epub 2015 Jan 22. Erratum in: Stroke. 2015 Mar;46(3):e73.


High prevalence of atrial fibrillation among patients with ischemic stroke.

Friberg L, Rosenqvist M, Lindgren A, Terént A, Norrving B, Asplund K.

Stroke. 2014 Sep;45(9):2599-605. doi: 10.1161/STROKEAHA.114.006070. Epub 2014 Jul 17.


[Anticoagulation in acute stroke with atrial fibrillation. Five questions should be answered before the treatment can be considered evidence-based].

Terént A, Åsberg S, Hijazi Z.

Lakartidningen. 2014 May 14-20;111(20):872-4. Swedish. No abstract available.


Warfarin-associated intracerebral hemorrhage after ischemic stroke.

Åsberg S, Eriksson M, Henriksson KM, Terént A.

Stroke. 2014 Jul;45(7):2118-20. doi: 10.1161/STROKEAHA.114.005729. Epub 2014 May 15.


Urgent carotid surgery and stenting may be safe after systemic thrombolysis for stroke.

Koraen-Smith L, Troëng T, Björck M, Kragsterman B, Wahlgren CM; Swedish Vascular Registry and the Riks-Stroke Collaboration.

Stroke. 2014 Mar;45(3):776-80. doi: 10.1161/STROKEAHA.113.003763. Epub 2014 Feb 13. Erratum in: Stroke. 2014 Apr;45(4):e67.


Trends in stroke treatment and outcome between 1995 and 2010: observations from Riks-Stroke, the Swedish stroke register.

Appelros P, Jonsson F, Åsberg S, Asplund K, Glader EL, Åsberg KH, Norrving B, Stegmayr B, Terént A; Riks-Stroke Collaboration.

Cerebrovasc Dis. 2014;37(1):22-9. doi: 10.1159/000356346. Epub 2013 Dec 17.


[HAS-BLED shows bleeding risk in ischemic stroke and atrial fibrillation. But adjustments are needed for safer assessment, according to quality study].

Alshakarchi J, Terént A.

Lakartidningen. 2012 Sep 19-26;109(38):1670-2. Swedish. No abstract available.


Reduced risk of death with warfarin - results of an observational nationwide study of 20 442 patients with atrial fibrillation and ischaemic stroke.

Åsberg S, Eriksson M, Henriksson KM, Terént A.

Int J Stroke. 2013 Dec;8(8):689-95. doi: 10.1111/j.1747-4949.2012.00855.x. Epub 2012 Aug 29.


The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.

IST-3 collaborative group, Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G, Innes K, Venables G, Czlonkowska A, Kobayashi A, Ricci S, Murray V, Berge E, Slot KB, Hankey GJ, Correia M, Peeters A, Matz K, Lyrer P, Gubitz G, Phillips SJ, Arauz A.

Lancet. 2012 Jun 23;379(9834):2352-63. doi: 10.1016/S0140-6736(12)60768-5. Epub 2012 May 23. Erratum in: Lancet. 2012 Aug 25;380(9843):730.


Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial.

Easton JD, Lopes RD, Bahit MC, Wojdyla DM, Granger CB, Wallentin L, Alings M, Goto S, Lewis BS, Rosenqvist M, Hanna M, Mohan P, Alexander JH, Diener HC; ARISTOTLE Committees and Investigators.

Lancet Neurol. 2012 Jun;11(6):503-11. doi: 10.1016/S1474-4422(12)70092-3. Epub 2012 May 8. Erratum in: Lancet Neurol. 2012 Dec;11(12):1021.


Supplemental Content

Loading ...
Support Center